Heiner has over 35 years’ experience in the global leadership of high-growth life sciences and healthcare businesses. Dr Dreismann was previously the President and CEO of Roche Molecular Systems, the world leader in molecular diagnostics, where he made significant contributions to the organizational and financial growth of the company’s molecular business area. Other senior positions he held in Roche included Head of Global Business Development, Roche Diagnostics and Member of Roche’s Global Diagnostic Executive Committee. Since leaving Roche he has served on the board of a number of private and public biotechnology and healthcare companies in the United States, Europe and Israel.

Board Member

Chairman of the Board

Board Member

Founder, CTO